Strategic Acquisition GlobalCare's integration into Covance enhances the company's global patient-centric decentralized clinical trial capabilities, presenting an opportunity to expand sales efforts targeting clients seeking innovative trial designs and international reach.

Market Leadership Receiving multiple industry awards and recognition, Covance demonstrates its reputation as a top-tier CRO, making it an attractive partner for pharmaceutical companies prioritizing proven expertise and high-quality clinical trial services.

Innovative Technology Utilization of advanced tools like Articulate Storyline, Qvidian, and Adobe Tag Manager indicates Covance’s commitment to cutting-edge digital solutions, opening possibilities for selling additional tech-enabled services or platform integrations.

Growth in Oncology Recent investments in preclinical oncology facilities in Michigan highlight a focused expansion in cancer research capabilities, offering potential opportunities for collaborations with oncology-focused biotechs and pharma firms.

Regulatory & Quality Focus Recognition with awards like the ACRP-Avoca CRO Quality Award underscores Covance's strong emphasis on compliance and quality, making it a compelling partner for clients prioritizing rigorous standards and risk mitigation.